首页|GnRHa联合孕激素治疗子宫内膜异位症的效果研究

GnRHa联合孕激素治疗子宫内膜异位症的效果研究

扫码查看
目的 探讨促性腺激素释放激素激动剂(GnRHa)联合孕激素治疗子宫内膜异位症的效果。方法 选取酒钢医院2021年2月至2022年3月收治的子宫内膜异位症患者212例,采用随机数表法将其分成两组,其中一组106例采用孕三烯酮治疗为对照组;另一组106例在对照组基础上增加醋酸戈舍瑞林缓释植入剂治疗为观察组。两组均治疗3个月,随访1年。比较两组各项指标。结果 观察组临床总有效率高于对照组,差异有统计学意义(P<0。05)。与治疗前比较,治疗后两组血清促卵泡生成素(FSH)、促黄体生成素(LH)、垂体泌乳素(PRL)、雌二醇(E2)、肿瘤坏死因子α(TNF-α)、基质金属蛋白酶-9(MMP-9)水平均降低,且观察组血清FSH、LH、PRL、E2、TNF-α、MMP-9水平低于对照组,差异有统计学意义(P<0。05)。与治疗前比较,治疗后两组血清过氧化氢酶(CAT)、超氧化物歧化酶(SOD)水平均升高,且观察组血清CAT、SOD水平高于对照组,差异有统计学意义(P<0。05)。观察组总不良妊娠率低于对照组,差异有统计学意义(P<0。05)。结论 GnRHa联合孕激素治疗可以有效提高子宫内膜异位症患者临床疗效,调节性激素水平,减轻炎症及氧化应激反应,改善妊娠结局。
Therapeutic effect of GnRHa combined with progesterone in the treatment of endometriosis
Objective To explore the therapeutic effect of gonadotropin releasing hormone agonist(GnRHa)combined with progesterone in the treatment of endometriosis.Methods A total of 2 1 2 patients with endometriosis admitted to Jiugang Hospital from February 2021 to March 2022 were selected.They were randomly divided into two groups using a random number table method,with one group consisting of 106 patients treated with gestrinone as the control group,and another group consisting of 106 patients treated with goserelin acetate sustained-release implant in addition to gestrinone as the observation group.Both groups were treated for 3 months and followed up for 1 year.The various indicators between the two groups were compared.Results The total clinical effective rate of the observation group was higher than that of the control group,with statistically significant differences(P<0.05).Compared with those before treatment,the serum levels of follicle-stimulating hormone(FSH),luteinizing hormone(LH),pituitary prolactin(PRL),estradiol(E2),tumor necrosis factor α(TNF-α),and matrix metalloproteinase-9(MMP-9)in the two groups after treatment were all reduced,and the serum levels of FSH,LH,PRL,E2,TNF-α,and MMP-9 in the observation group were lower than those in the control group,with statistically significant differences(P<0.05).Compared with those before treatment,the levels of serum catalase(CAT)and superoxide dismutase(SOD)in both groups increased after treatment,and the observation group had higher levels of serum CAT and SOD than the control group,with statistically significant differences(P<0.05).The total incidence of adverse pregnancies in the observation group was lower than that in the control group,with statistically significant differences(P<0.05).Conclusion The combination of GnRHa and progesterone therapy can effectively improve the clinical efficacy of patients with endometriosis,regulate sex hormone levels,alleviate inflammation and oxidative stress reactions,and improve pregnancy outcomes.

Gonadotropin releasing hormone agonistProgesteroneEndometriosisSex hormone

赵丹

展开 >

甘肃省酒钢医院妇产科,甘肃嘉峪关 735100

促性腺激素释放激素激动剂 孕激素 子宫内膜异位症 性激素

2024

中国医药科学
海峡两岸医药卫生交流协会 二十一世纪联合创新(北京)医药科学研究院

中国医药科学

影响因子:1.083
ISSN:2095-0616
年,卷(期):2024.14(8)
  • 16